A Specific Antibody to Vasopressin in a Man with Concomitant Resistance to Treatment with Pitressin

Line
Title: A Specific Antibody to Vasopressin in a Man with Concomitant Resistance to Treatment with Pitressin
Authors: Bichet, Daniel G.; Kortas, MD, Claude; Manzini, Christiane; Barjon, MD, Jean-Noel
Publisher: Clinical Chemistry
Date Published: January 01, 1986
Reference Number: 451
Line
A 26-year-old man with complete neurogenic diabetes insipidus since age nine was initially treated with vasopressin (Pitressin Tannate in oil). At age 13, its dosages were progressively increased to control the patient's polyuria; minor allergic symptoms occurred after every such treatment. We incubated serial dilutions of the patient's plasma with 125I-labeled arginine-vasopressin and obtained a 50% specific binding for the plasma at a final dilution of 625-fold. Cross-reactivity studies showed that lysine-vasopressin was better recognized by the antibody than arginine-vasopressin. These results were attributed to large concentrations of lysine-vasopressin (pork vasopressin) in the Pitressin.

The publisher has not granted permission to reproduce this article on our website. You may, however, read this article at the Clinical Chemistry website. In order to view this document, you will need Acrobat Reader. If you do not already have Acrobat Reader or need to upgrade, click here.
To return to this page, use your "back" key.